Concepedia

Victor Kenyon

VK

Statistics

Publications

20

Citations

1.4K

H-Index

18

Active since

2004

Affiliations

University of California, Santa Cruz(Current)

National Institutes of Health

Massachusetts General Hospital

Harvard University

University of California, San Francisco

Victor Kenyon is an author at University of California, Santa Cruz specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2004–2024

20

Publications

20

Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases

Joshua D. Deschamps, Victor Kenyon, Theodore R. Holman · Bioorganic & Medicinal Chemistry · 2006 · 164 citations · Full text

, , +5

Integration of pro-inflammatory cytokines, 12-lipoxygenase and NOX-1 in pancreatic islet beta cell dysfunction

Jessica R. Weaver, Theodore R. Holman, Yumi Imai et al. · Molecular and Cellular Endocrinology · 2012 · 131 citations · Full text

, , +14

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

, , +16

Potent and Selective Inhibitors of Human Reticulocyte 12/15-Lipoxygenase as Anti-Stroke Therapies

Ganesha Rai, Netra Joshi, Joo Eun Jung et al. · Journal of Medicinal Chemistry · 2014 · 95 citations · Full text

, , +14

Novel Human Lipoxygenase Inhibitors Discovered Using Virtual Screening with Homology Models

Victor Kenyon, Ilya Chorny, Wendy J. Carvajal et al. · Journal of Medicinal Chemistry · 2006 · 85 citations · Full text

, , +17

1–5 of 20